TrinityPoint Wealth’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,000
Closed -$1.22K – 298
2022
Q4
$1.22K Hold
11,000
– – ﹤0.01% 279
2022
Q3
$12K Hold
11,000
– – ﹤0.01% 278
2022
Q2
$20K Hold
11,000
– – ﹤0.01% 276
2022
Q1
$39K Hold
11,000
– – 0.01% 307
2021
Q4
$95K Sell
11,000
-3,250
-23% -$20.7K 0.02% 302
2021
Q3
$108K Buy
14,250
+2,250
+19% +$19K 0.02% 301
2021
Q2
$80K Buy
+12,000
New +$75.6K 0.02% 262

Other funds holding LHDX

TrinityPoint Wealth's LHDX Position: Q1 2023 in Review

TrinityPoint Wealth sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 11,000 shares — an estimated $1.22K sold.

TrinityPoint Wealth first reported a position in LHDX in Q2 2021 and held it in 7 quarters. The position peaked at $108K in Q3 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • TrinityPoint Wealth reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • TrinityPoint Wealth sold 11,000 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $1.22K.
  • TrinityPoint Wealth first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • TrinityPoint Wealth's Lucira Health, Inc. Common Stock position peaked at $108K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on TrinityPoint Wealth's 13F filing for Q1 2023, filed 4 May 2023.